Part D Preferred Pharmacy Networks Need More CMS Oversight, Senators Say
This article was originally published in The Pink Sheet Daily
Executive Summary
The bipartisan group of senators asks the agency to detail steps designed to ensure that Part D plans with preferred networks are not increasing costs to Medicare or impeding beneficiary access to drugs.
You may also be interested in...
Medicare Part D Plans Expanding Five-Tier Formularies, Preferred Networks In 2013
A review of Part D plan design trends among the leading sponsors shows that Humana has switched to five-tier formularies, UnitedHealth is using a preferred pharmacy network and CVS Caremark is sponsoring plans that include community-based independents in its preferred network.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.